Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proxalutamide for Hospitalized COVID-19
NCT04728802Phase 3Completed
- Start
- Feb 2021
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of proxalutamide in coronavirus disease 2019 (COVID-19). Started Feb 2021; status: completed.
02
Drugs
proxalutamide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04728802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04728802.